The customer suspected the reagent readypack due to extremely low quality control and patient results.The customer stores some of their readypacks in closed boxes when in the refrigerator.The refrigerator where the readypacks are stored has glass doors and sometimes the internal light below the readypacks was left on.The customer cannot say whether the boxes are close to the light.Siemens healthcare diagnostics recommended to the customer to store ca15-3 reagent kits as far away from the light as possible.The cause for the discordant advia centaur xpt ca15-3 results is unknown.The instrument is performing within specifications.No further evaluation of the device is required.The ifu states in the storing and stability section: "store the reagents upright at 2-8°c.Protect reagent packs from all heat and light sources.Reagent packs loaded on the system are protected from light.Store unused reagent packs at 2-8°c away from heat and light sources.All reagents are stable at 2-8°c until the expiration date on the packaging." the ifu states in the limitation section: "note: do not interpret levels of ca 15-3 as absolute evidence of the presence or the absence of malignant disease.Before treatment, patients with confirmed breast carcinoma frequently have levels of ca 15-3 within the range observed in healthy individuals.Additionally, elevated levels of ca 15-3 can be observed in patients with nonmalignant diseases.Measurements of ca 15-3 should always be used in conjunction with other diagnostic procedures, including information from the patient's clinical evaluation." note: product availability may vary from country to country and is subject to varying regulatory requirements.Due to local regulations, the advia centaur xpt is not available in all countries.
|